Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 6Phase 1 4Phase NA 1Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 18Lymphoma 9Sarcoma 8Nausea 5Vomiting 4Lymphoma, Non-Hodgkin 4Carcinoma, Hepatocellular 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Large B-Cell, Diffuse 3Recurrence 2Osteosarcoma 2Neuroblastoma 2Neoplasm Metastasis 2Motor Activity 2Lymphoma, Large-Cell, Anaplastic 2Leukemia 2Breast Neoplasms, Male 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Somatostatinoma 1Sezary Syndrome 1Sarcoma, Synovial 1Sarcoma, Ewing 1Peritoneal Neoplasms 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1

Interventions

Zidovudine 3Methotrexate 2Leucovorin 2Dexamethasone 2fludarabine phosphate 1X-Rays 1Whole-Body Irradiation 1Vincristine 1Triage 1Transurethral Resection of Prostate 1Therapeutics 1Tetanus Toxoid 1Standard of Care 1Smoking Devices 1Semaxinib 1Practice Guidelines as Topic 1Pneumococcal Vaccines 1Peripheral Blood Stem Cell Transplantation 1Papillomavirus Vaccines 1Papanicolaou Test 1Mycophenolic Acid 1Measles-Mumps-Rubella Vaccine 1Massage 1Mass Screening 1Inosine Pranobex 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Heptavalent Pneumococcal Conjugate Vaccine 1Hepatitis B Vaccines 1Health Promotion 1Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × HIV Infections × Doxorubicin × Clear all
NCT00000703 2021-11-03

Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

National Institute of Allergy and Infectious Diseases (NIAID)

Phase NA Completed
45 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Lymphoma, Non-Hodgkin, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡